Skip to main content

Table 2 Clinical and biological characteristics of the two GIST patients series according to KITL541

From: KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

Clinical and biological characteristics

KIT L541

KIT M541

P b

N

24

85

 

Median size (mm)

50 (17–240)

60 (20–400)

 

Location

   

 Stomach

12 (50 %)

48 (56 %)

0.6

 Small bowel

7 (29 %)

28 (33 %)

1

Mitotic index

   

  ≤ 5

11 (50 %)a

46 (54 %)

0.8

 6–10

2 (9 %)a

15 (18 %)

0.5

  > 10

9 (41 %)a

24 (28 %)

0.4

Mutation status

   

KIT Mutations

15 (75 %)a

49 (70 %)a

0.8

KIT exon 11

10 (50 %)a

42 (60 %)a

0.5

KIT exon 9

3 (15 %)a

5 (7 %)a

0.4

KIT exon 13

2 (10 %)a

0

n/a

KIT exon 17

0

2 (3 %)a

n/a

PDGFRA Mutations

2 (10 %)a

9 (13 %)a

1

PDGFRA exon 18 D842V

1

8

 

 Wild Type

3 (15 %)a

12 (17 %)a

1

 Undetermined

4

15

 

Stage of the disease at diagnosis

   

 Localized

15 (62 %)

72 (85 %)

0.02

 Metastatic (or locally advanced/unresectable)

9 (38 %)

13 (15 %)

  1. aPercentages are determined on the evaluable cases
  2. bChi-square test or Fisher’s exact test were applied as appropriate to check for differences according to the presence of KITL541